tiprankstipranks
Global Blood Therapeutics (GBT)
NASDAQ:GBT

Global Blood Therapeutics (GBT) Financial Statements

0 Followers

Global Blood Therapeutics Financial Overview

Global Blood Therapeutics's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Global Blood Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Mar 22Dec 21Sep 21Jun 21
Income Statement-
Total Revenue$ 71.55M$ 55.16M$ 56.10M$ 52.05M$ 47.55M
Gross Profit$ 70.14M$ 54.10M$ 54.95M$ 51.22M$ 46.81M
EBIT$ -73.88M$ -73.05M$ -82.71M$ -67.28M$ -65.92M
EBITDA$ -71.57M$ -70.78M$ -80.49M$ -65.09M$ -63.75M
Net Income Common Stockholders$ -82.47M$ -81.42M$ -87.58M$ -70.99M$ -69.59M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 517.16M$ 553.42M$ 684.72M$ 386.07M$ 437.40M
Total Assets$ 870.44M$ 869.54M$ 939.21M$ 607.68M$ 614.97M
Total Debt$ 658.39M$ 659.05M$ 659.62M$ 229.95M$ 230.95M
Net Debt$ 141.23M$ 105.63M$ -25.10M$ -156.12M$ -206.44M
Total Liabilities$ 752.08M$ 735.54M$ 742.80M$ 299.38M$ 299.21M
Stockholders Equity$ 118.36M$ 134.00M$ 196.41M$ 308.30M$ 315.77M
Cash Flow-
Free Cash Flow$ -44.69M$ -72.11M$ -68.98M$ -65.57M$ -45.11M
Operating Cash Flow$ -44.31M$ -71.85M$ -67.93M$ -65.31M$ -44.32M
Investing Cash Flow$ -134.66M$ -222.50M$ -17.51M$ -16.13M$ 17.75M
Financing Cash Flow$ 48.60M$ 1.60M$ 387.17M$ 45.09M$ 292.00K
Currency in USD

Global Blood Therapeutics Earnings and Revenue History

Global Blood Therapeutics Debt to Assets

Global Blood Therapeutics Cash Flow

Global Blood Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis